References
- Alzheimer’s Disease International Consortium [webpage on the Internet]World Alzheimer Report 2015 Available from: http://www.alz.co.uk/research/WorldAlzheimerReport2015.pdfAccessed April 11, 2016
- BlennowKde LeonMJZetterbergHAlzheimer’s diseaseLancet2006368953338740316876668
- GatzMReynoldsCAFratiglioniLRole of genes and environments for explaining Alzheimer diseaseArch Gen Psychiatry200663216817416461860
- BuGApolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapyNat Rev Neurosci200910533334419339974
- HuangYMuckeLAlzheimer mechanisms and therapeutic strategiesCell201214861204122222424230
- NajACJunGBeechamGWCommon variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s diseaseNat Genet201143543644121460841
- SeshadriSFitzpatrickALIkramMAGenome-wide analysis of genetic loci associated with Alzheimer diseaseJAMA2010303181832184020460622
- BertramLNext generation sequencing in Alzheimer’s diseaseMethods Mol Biol2016130328129726235074
- TanziREBertramLTwenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspectiveCell2005120454555515734686
- VerghesePBCastellanoJMHoltzmanDMApolipoprotein E in Alzheimer’s disease and other neurological disordersLancet Neurol201110324125221349439
- HattersleyATMcCarthyMIA question of standards: what makes a good genetic association study?Lancet200536694931315132316214603
- KarchCMCruchagCGoateAMAlzheimer’s disease genetics: from the bench to the clinicNeuron2014831112624991952
- CrutsMTheunsJVan BroeckhovenCLocus-specific mutation databases for neurodegenerative brain diseasesHum Mutat20123391340134422581678
- YoshikaiSSasakiHDoh-uraKFuruyaHSakakiYGenomic organization of the human amyloid beta-protein precursor geneGene19908722572632110105
- ThinakaranGKooEHAmyloid precursor protein trafficking, processing and functionJ Biol Chem200828344296152961918650430
- BekrisLMYuCEBirdTDTsuangDWGenetics of Alzheimer diseaseJ Geriatr Psychiatry Neurol201023421322721045163
- GuerreiroRJGustafsonDRHardyJThe genetic architecture of Alzheimer’s disease: beyond APP, PSENs and APOENeurobiol Aging201233343745620594621
- De JongheCEsselensCKumar-SinghSPathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stabilityHum Mol Genet200110161665167111487570
- MullanMCrawfordFAxelmanKA pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of β-amyloidNat Genet1992153453471302033
- PrasherVPFarrerMJKesslingAMMolecular mapping of Alzheimer-type dementia in Down’s syndromeAnn Neurol19984333803839506555
- GoateAChartier-HarlinMCMullanMSegregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s diseaseNature199134963117047061671712
- NilsberthCWestlind-DanielssonAEckmanCBThe ‘Arctic’ APP mutation (E693G) causes Alzheimer’s disease by enhanced Abeta protofibril formationNat Neurosci20014988789311528419
- KaminoKOrrHTPayamiHLinkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene regionAm J Hum Genet199251599810141415269
- HendriksLvan DuijnCMCrasPPresenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein geneNat Genet1992132182211303239
- JonssonTAtwalJKSteinbergSA mutation in APP protects against Alzheimer’s disease and age-related cognitive declineNature20124887409969922801501
- EslerWPWolfeMSA portrait of Alzheimer secretases – new features and familiar facesScience200129355341449145411520976
- SteinerHUncovering gamma-secretaseCurr Alzheimer Res20041317518115975065
- SteinerHReveszTNeumannMA pathogenic presenilin-1 deletion causes aberrant Abeta 42 production in the absence of congophilic amyloid plaquesJ Biol Chem2001276107233723911084029
- TakaoMGhettiBHayakawaIA novel mutation (G217D) in the Presenilin 1 gene (PSEN1) in a Japanese family: presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatumActa Neuropathol2002104215517012111359
- VerkkoniemiAKalimoHPaetauAVariant Alzheimer disease with spastic paraparesis: neuropathological phenotypeJ Neuropathol Exp Neurol200160548349211379823
- BreyhanHWirthsODuanKMarcelloARettigJBayerTAAPP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophyActa Neuropathol2009117667768519387667
- PiginoGMorfiniGPelsmanAMattsonMPBradySTBusciglioJAlzheimer’s presenilin 1 mutations impair kinesin-based axonal transportJ Neurosci200323114499450812805290
- WakabayashiTDe StrooperBPresenilins: members of the gamma-secretase quartets, but part-time soloists tooPhysiology (Bethesda)200823419420418697993
- JayadevSLeverenzJBSteinbartEAlzheimer’s disease phenotypes and genotypes associated with mutations in presenilin 2Brain201013341143115420375137
- ParkMHChoiDYJinHWMutant presenilin 2 increases β-secretase activity through reactive oxygen species-dependent activation of extracellular signal-regulated kinaseJ Neuropathol Exp Neurol201271213013922249458
- BentahirMNyabiOVerhammeJPresenilin clinical mutations can affect gamma-secretase activity by different mechanismsJ Neurochem200696373274216405513
- HaroldDAbrahamRHollingworthPGenome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s diseaseNat Genet200941101088109319734902
- LambertJCIbrahim-VerbaasCAHaroldDEuropean Alzheimer’s Disease Initiative (EADI)Genetic and Environmental Risk in Alzheimer’s DiseaseAlzheimer’s Disease Genetic ConsortiumCohorts for Heart and Aging Research in Genomic EpidemiologyMeta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s diseaseNat Genet201345121452145824162737
- BertramLLangeCMullinKGenome-wide association analysis reveals putative Alzheimer’s disease susceptibility loci in addition to APOEAm J Hum Genet200883562363218976728
- SolomonAKivipeltoMWolozinBZhouJWhitmerRAMidlife serum cholesterol and increased risk of Alzheimer’s and vascular dementia three decades laterDement Geriatr Cogn Disord2009281758019648749
- CorderEHSaundersAMStrittmatterWJGene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset familiesScience199326151239219238346443
- SaundersAMStrittmatterWJSchmechelDAssociation of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s diseaseNeurology1993438146714728350998
- SaundersAMApolipoprotein E and Alzheimer disease: an update on genetic and functional analysesJ Neuropathol Exp Neurol200059975175811005255
- RosesADApolipoprotein E alleles as risk factors in Alzheimer’s diseaseAnnu Rev Med1996473874008712790
- MahleyRWWeisgraberKHHuangYApolipoprotein E: structure determines function, from atherosclerosis to Alzheimer’s disease to AIDSJ Lipid Res200950supplS183S18819106071
- HerzJChenYMasiulisIZhouLExpanding functions of lipoprotein receptorsJ Lipid Res200950supplS287S29219017612
- GajeraCREmichHLioubinskiOLRP2 in ependymal cells regulates BMP signaling in the adult neurogenic nicheJ Cell Sci2010123111922193020460439
- PastorPRoeCMVillegasAApolipoprotein Eepsilon4 modifies Alzheimer’s disease onset in an E280A PS1 kindredAnn Neurol200354216316912891668
- VélezJILoperaFSepulveda-FallaDAPOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer’s diseaseMol Psychiatry Epub2015121
- CastellanoJMKimJStewartFRHuman apoE isoforms differentially regulate brain amyloid-β peptide clearanceSci Transl Med201138989ra57
- KimJBasakJMHoltzmanDMThe role of apolipoprotein E in Alzheimer’s diseaseNeuron200963328730319679070
- BalesKRLiuFWuSHuman APOE isoform-dependent effects on brain β-amyloid levels in PDAPP transgenic miceJ Neurosci200929216771677919474305
- KokEHaikonenSLuotoTApolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle ageAnn Neurol200965665065719557866
- PolvikoskiTSulkavaRHaltiaMApolipoprotein E, dementia, and cortical deposition of beta-amyloid proteinN Engl J Med199533319124212477566000
- DoreyEChangNLiuQYYangZZhangWApolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s diseaseNeurosci Bull201430231733024652457
- HanMRSchellenbergGDWangLSAlzheimer’s Disease Neuroimaging InitiativeGenome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control studyBMC Neurol2010109020932310
- ChiangGCInselPSTosunDAlzheimer’s Disease Neuroimaging InitiativeHippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjectsNeurology201075221976198120980669
- LaDuMJFaldutoMTManelliAMReardonCAGetzGSFrailDEIsoform-specific binding of apolipoprotein E to beta-amyloidJ Biol Chem19942693823403234068089103
- PoirierJApolipoprotein E and Alzheimer’s disease. A role in amyloid catabolismAnn N Y Acad Sci2000924819011193807
- LuPHThompsonPMLeowAApolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry studyJ Alzheimers Dis201123343344221098974
- PotkinSGGuffantiGLakatosAAlzheimer’s Disease Neuroimaging InitiativeHippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer’s diseasePLoS One200948e650119668339
- RamananVKRisacherSLNhoKAlzheimer’s Disease Neuroimaging InitiativeAPOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association studyMol Psychiatry201419335135723419831
- YatesPADesmondPMPhalPMAIBL Research GroupIncidence of cerebral microbleeds in preclinical Alzheimer diseaseNeurology201482141266127324623839
- LambertJCHeathSEvenGGenome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s diseaseNat Genet200941101094109919734903
- NuutinenTSuuronenTKauppinenASalminenAClusterin: a forgotten player in Alzheimer’s diseaseBrain Res Rev20096128910419651157
- JonesSEJomaryCClusterinInt J Biochem Cell Biol200234542743111906815
- RosenbergMESilkensenJClusterin: physiologic and pathophysiologic considerationsInt J Biochem Cell Biol19952776336457648419
- LidströmAMBogdanovicNHesseCVolkmanIDavidssonPBlennowKClusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer’s diseaseExp Neurol199815425115219878186
- SchrijversEMKoudstaalPJHofmanABretelerMMPlasma clusterin and the risk of Alzheimer diseaseJAMA2011305131322132621467285
- KarchCMJengATNowotnyPCadyJCruchagaCGoateAMExpression of novel Alzheimer’s disease risk genes in control and Alzheimer’s disease brainsPLoS One2012711e5097623226438
- DemingYXiaJCaiYAlzheimer’s Disease Neuroimaging Initiative (ADNI)A potential endophenotype for Alzheimer’s disease: cerebrospinal fluid clusterinNeurobiol Aging201637208.e1208.e926545630
- HollingworthPHaroldDSimsRCommon variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s diseaseNat Genet201143542943521460840
- KimWSGuilleminGJGlarosENLimCKGarnerBQuantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cellsNeuroreport200617989189616738483
- HoltonPRytenMNallsMInitial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk LociAnn Hum Genet20137728510523360175
- ReitzCJunGNajAAlzheimer Disease Genetics ConsortiumVariants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E∈4, and the risk of late-onset Alzheimer disease in African AmericansJAMA2013309141483149223571587
- KimWSLiHRuberuKDeletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer’s diseaseJ Neurosci201333104387439423467355
- ChanSLKimWSKwokJBATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitroJ Neurochem2008106279380418429932
- SteinbergSStefanssonHJonssonTLoss-of-function variants in ABCA7 confer risk of Alzheimer’s diseaseNat Genet201547544544725807283
- AndersenOMReicheJSchmidtVNeuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor proteinProc Natl Acad Sci U S A200510238134611346616174740
- FjorbackAWSeamanMGustafsenCRetromer binds the FANSHY sorting motif in SorLA to regulate amyloid precursor protein sorting and processingJ Neurosci20123241467148022279231
- GustafsenCGlerupSPallesenLTSortilin and SorLA display distinct roles in processing and trafficking of amyloid precursor proteinJ Neurosci2013331647123283322
- RogaevaEMengYLeeJHThe neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer diseaseNat Genet200739216817717220890
- TsolakidouAAlexopoulosPGuoLHBeta-Site amyloid precursor protein-cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin-related receptor with A-type repeats, soluble amyloid precursor protein, and tauAlzheimers Dement20139438639123127467
- OffeKDodsonSEShoemakerJTThe lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartmentsJ Neurosci20062651596160316452683
- CapsoniSCarloASVignoneDSorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer’s diseaseJ Alzheimers Dis201333235737122986780
- LeeJHBarralSReitzCThe neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer’s diseaseCurr Neurol Neurosci Rep20088538439118713574
- ReitzCChengRRogaevaEGenetic and Environmental Risk in Alzheimer Disease 1 ConsortiumMeta-analysis of the association between variants in SORL1 and Alzheimer diseaseArch Neurol20116819910621220680
- CuencoKTLunettaKLBaldwinCTAssociation of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer diseaseArch Neurol200865121640164819064752
- De StrooperBAnnaertWProteolytic processing and cell biological functions of the amyloid precursor proteinJ Cell Sci2000113pt 111857187010806097
- WangZLeiHZhengMLiYCuiYHaoFMeta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1Mol Neurobiol Epub20151127
- WilsonJGAndriopoulosNAFearonDTCR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical reviewImmunol Res1987631922092960763
- KheraRDasNComplement Receptor 1: disease associations and therapeutic implicationsMol Immunol200946576177219004497
- BonifatiDMKishoreURole of complement in neurodegeneration and neuroinflammationMol Immunol2007445999101016698083
- KokEHLuotoTHaikonenSGoebelerSHaapasaloHKarhunenPJCLU, CR1 and PICALM genes associate with Alzheimer’s-related senile plaquesAlzheimers Res Ther2011321221466683
- BraltenJFrankeBArias-VasquezACR1 genotype is associated with entorhinal cortex volume in young healthy adultsNeurobiol Aging201132112106.e72106.e1121726919
- BrouwersNVan CauwenbergheCEngelborghsSAlzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sitesMol Psychiatry201217222323321403675
- BiffiAShulmanJMJagiellaJMGenetic variation at CR1 increases risk of cerebral amyloid angiopathyNeurology201278533434122262751
- JandusCSimonHUvon GuntenSTargeting Siglecs – a novel pharmacological strategy for immuno- and glycotherapyBiochem Pharmacol201182432333221658374
- TatenoHLiHSchurMJDistinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunityMol Cell Biol200727165699571017562860
- GriciucASerrano-PozoAParradoARAlzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid betaNeuron201378463164323623698
- BradshawEMChibnikLBKeenanBTCD33 Alzheimer’s disease locus: altered monocyte function and amyloid biologyNat Neurosci201316784885023708142
- ZuccoloJDengLUnruhTLExpression of MS4A and TMEM176 genes in human B lymphocytesFront Immunol2013419523874341
- AntunezCBoadaMGonzalez-PerezAAlzheimer’s Disease Neuroimaging InitiativeThe membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer’s diseaseGenome Med2011353321627779
- JonssonTStefanssonHSteinbergSVariant of TREM2 associated with the risk of Alzheimer’s diseaseN Engl J Med2013368210711623150908
- GuerreiroRWojtasABrasJAlzheimer Genetic Analysis GroupTREM2 variants in Alzheimer’s diseaseN Engl J Med2013368211712723150934
- JinSCBenitezBAKarchCMCoding variants in TREM2 increase risk for Alzheimer’s diseaseHum Mol Genet201423215838584624899047
- GuerreiroRJLohmannEBrásJMUsing exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvementJAMA Neurol2013701788423318515
- PalonevaJKestiläMWuJLoss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cystsNat Genet200025335736110888890
- PalonevaJManninenTChristmanGMutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotypeAm J Hum Genet200271365666212080485
- RayaproluSMullenBBakerMTREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s diseaseMol Neurodegener201381923800361
- CadyJKovalEDBenitezBATREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosisJAMA Neurol201471444945324535663
- CruchagaCKauweJSHarariOGERAD ConsortiumAlzheimer’s Disease Neuroimaging Initiative (ADNI)Alzheimer Disease Genetic Consortium (ADGC)GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer’s diseaseNeuron201378225626823562540
- RajagopalanPHibarDPThompsonPMTREM2 and neurodegenerative diseaseN Engl J Med2013369161565156724131186
- PantSSharmaMPatelKCaplanSCarrCMGrantBDAMPH-1/Amphiphysin/Bin1 functions with RME-1/Ehd1 in endocytic recyclingNat Cell Biol200911121399141019915558
- TanMSYuJTTanLBridging integrator 1 (BIN1): form, function, and Alzheimer’s diseaseTrends Mol Med2013191059460323871436
- KambohMIDemirciFYWangXGenome-wide association study of Alzheimer’s diseaseTransl Psychiatry20122e11722832961
- BiffiAAndersonCDDesikanRSGenetic variation and neuroimaging measures in Alzheimer diseaseArch Neurol201067667768520558387
- ChapuisJHansmannelFGistelinckMIncreased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathologyMol Psychiatry201318111225123423399914
- MonzoPGauthierNCKeslairFClues to CD2-associated protein involvement in cytokinesisMol Biol Cell20051662891290215800069
- ShulmanJMChenKKeenanBTGenetic susceptibility for Alzheimer disease neuritic plaque pathologyJAMA Neurol20137091150115723836404
- LiaoFJiangHSrivatsanSEffects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse modelMol Neurodegener2015101225887956
- ChenHWuGJiangYAnalyzing 54,936 samples supports the association between CD2AP rs9349407 polymorphism and Alzheimer’s disease susceptibilityMol Neurobiol20155211725092125
- XiaoQGilSCYanPRole of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesisJ Biol Chem201228725212792128922539346
- MelvilleSABurosJParradoARAlzheimer’s Disease Neuroimaging InitiativeMultiple loci influencing hippocampal degeneration identified by genome scanAnn Neurol2012721657522745009
- SchjeideBMSchnackCLambertJCThe role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levelsArch Gen Psychiatry201168220721321300948
- BaigSJosephSATaylerHDistribution and expression of picalm in Alzheimer diseaseJ Neuropathol Exp Neurol201069101071107720838239
- ZhaoZSagareAPMaQCentral role for PICALM in amyloid-β blood-brain barrier transcytosis and clearanceNat Neurosci201518797898726005850
- MoreauKFlemingAImarisioSPICALM modulates autophagy activity and tau accumulationNat Commun20145499825241929
- TreuschSHamamichiSGoodmanJLFunctional links between Abeta toxicity, endocytic trafficking, and Alzheimer’s disease risk factors in yeastScience201133460601241124522033521
- MorgenKRamirezAFrölichLGenetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer’s diseaseAlzheimers Dement2014105 supplS269S27624613704
- LaiKOIpNYSynapse development and plasticity: roles of ephrin/Eph receptor signalingCurr Opin Neurobiol200919327528319497733
- YamazakiTMasudaJOmoriTUsuiRAkiyamaHMaruYEphA1 interacts with integrin-linked kinase and regulates cell morphology and motilityJ Cell Sci2009122pt 224325519118217
- WangHFTanLHaoXKEffect of EPHA1 genetic variation on cerebrospinal fluid and neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer’s disease cohortsJ Alzheimers Dis201544111512325182741
- RuizAHeilmannSBeckerTFollow-up of loci from the International Genomics of Alzheimer’s Disease Project identifies TRIP4 as a novel susceptibility geneTransl Psychiatry20144e35824495969
- GuerreiroRBrásJHardyJSnapShot: genetics of Alzheimer’s diseaseCell20131554968968.e124209629
- LangHLJacobsenHIkemizuSA functional and structural basis for TCR cross-reactivity in multiple sclerosisNat Immunol200231094094312244309
- HamzaTHZabetianCPTenesaACommon genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s diseaseNat Genet201042978178520711177
- ChenZShojaeeSBuchnerMSignalling thresholds and negative B-cell selection in acute lymphoblastic leukaemiaNature2015521755235736125799995
- ViernesDRChoiLBKerrWGChisholmJDDiscovery and development of small molecule SHIP phosphatase modulatorsMed Res Rev201434479582424302498
- NowakowskaBAObersztynESzymanskaKSevere mental retardation, seizures, and hypotonia due to deletions of MEF2CAm J Med Genet B Neuropsychiatr Genet2010153b51042105120333642
- ClarkRITanSWPéanCBMEF2 is an in vivo immune-metabolic switchCell2013155243544724075010
- SinghMKDadkeDNicolasEA novel Cas family member, HEPL, regulates FAK and cell spreadingMol Biol Cell20081941627163618256281
- BeechamGWHamiltonKNajACGenome-wide association meta-analysis of neuropathologic features of Alzheimer’s disease and related dementiasPLoS Genet2014109e100460625188341
- RosenthalSLBarmadaMMWangXDemirciFYKambohMIConnecting the dots: potential of data integration to identify regulatory SNPs in late-onset Alzheimer’s disease GWAS findingsPLoS One201494e9515224743338
- BeckTNNicolasEKoppMCGolemisEAAdaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s diseaseOncoscience20141748650325594051
- AlierKAMorrisBJDivergent regulation of Pyk2/CAKbeta phosphorylation by Ca2+ and cAMP in the hippocampusBiochim Biophys Acta20051745334234916120467
- JiaoBLiuXZhouLPolygenic analysis of late-onset Alzheimer’s disease from mainland ChinaPLoS One20151012e014489826680604
- KaufmanACSalazarSVHaasLTFyn inhibition rescues established memory and synapse loss in Alzheimer miceAnn Neurol201577695397125707991
- KimSHFountoulakisMCairnsNJLubecGHuman brain nucleoside diphosphate kinase activity is decreased in Alzheimer’s disease and Down syndromeBiochem Biophys Res Commun2002296497097512200143
- LiuYYuJTWangHFAssociation between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer’s diseasePLoS One2014912e11477725486118
- DuriezBDuquesnoyPEscudierEA common variant in combination with a nonsense mutation in a member of the thioredoxin family causes primary ciliary dyskinesiaProc Natl Acad Sci U S A20071043336334117360648
- ShiDNakamuraTNakajimaMAssociation of single-nucleotide polymorphisms in RHOB and TXNDC3 with knee osteoarthritis susceptibility: two case-control studies in East Asian populations and a meta-analysisArthritis Res Ther2008103R5418471322
- HeFUmeharaTSaitoKStructural insight into the zinc finger CW domain as a histone modification readerStructure20101891127113920826339
- AllenMKachadoorianMCarrasquilloMMLate-onset Alzheimer disease risk variants mark brain regulatory lociNeurol Genet201512e1527066552
- BeisangDReillyCBohjanenPRAlternative polyadenylation regulates CELF1/CUGBP1 target transcripts following T cell activationGene201455019310025123787
- HouseRPTalwarSHazardESHillEGPalanisamyVRNA-binding protein CELF1 promotes tumor growth and alters gene expression in oral squamous cell carcinomaOncotarget2015641436204363426498364
- XiaLSunCLiQCELF1 is up-regulated in glioma and promotes glioma cell proliferation by suppression of CDKN1BInt J Biol Sci201511111314132426535026
- Kuyumcu-MartinezNMWangGSCooperTAIncreased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylationMol Cell2007281687817936705
- ShulmanJMImboywaSGiagtzoglouNFunctional screening in Drosophila identifies Alzheimer’s disease susceptibility genes and implicates Tau-mediated mechanismsHum Mol Genet201423487087724067533
- KahnerBNKatoHBannoAGinsbergMHShattilSJYeFKindlins, integrin activation and the regulation of talin recruitment to αIIbβ3PLoS One201273e3405622457811
- ZhanJZhuXGuoYOpposite role of Kindlin-1 and Kindlin-2 in lung cancersPLoS One2012711e5031323209705
- YuYWuJGuanLKindlin 2 promotes breast cancer invasion via epigenetic silencing of the microRNA200 gene familyInt J Cancer201313361368137923483548
- ShenZYeYKauttuTNovel focal adhesion protein kindlin-2 promotes the invasion of gastric cancer cells through phosphorylation of integrin beta1 and beta3J Surg Oncol2013108210611223857544
- DowlingJJVreedeAPKimSGoldenJFeldmanELKindlin-2 is required for myocyte elongation and is essential for myogenesisBMC Cell Biol200893618611274
- PluskotaEDowlingJJGordonNThe integrin coactivator kindlin-2 plays a critical role in angiogenesis in mice and zebrafishBlood2011117184978498721378273
- LarssonMDuffyDLZhuGGWAS findings for human iris patterns: associations with variants in genes that influence normal neuronal pattern developmentAm J Hum Genet201189233434321835309
- HanJKraftPNanHA genome-wide association study identifies novel alleles associated with hair color and skin pigmentationPLoS Genet200845e100007418483556
- YuLChibnikLBSrivastavaGPAssociation of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer diseaseJAMA Neurol2015721152425365775
- KajihoHSaitoKTsujitaKRIN3: a novel Rab5 GEF interacting with amphiphysin II involved in the early endocytic pathwayJ Cell Sci2003116204159416812972505
- KrajaATBoreckiIBTsaiMYGenetic analysis of 16 NMR-lipoprotein fractions in humans, the GOLDN studyLipids201348215516523192668
- ZhangMXueAShenYMutations of desmoglein-2 in sudden death from arrhythmogenic right ventricular cardiomyopathy and sudden unexplained deathForensic Sci Int2015255858826296472
- RamaniVCHenningsLHaunRSDesmoglein 2 is a substrate of kallikrein 7 in pancreatic cancerBMC Cancer2008837319091121
- KurzenHMunzingIHartschuhWExpression of desmosomal proteins in squamous cell carcinomas of the skinJ Cutan Pathol2003301062163014744087
- OsisamiMAliWFrohmanMAA role for phospholipase D3 in myotube formationPLoS One201273e3334122428023
- CruchagaCKarchCMJinSCRare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s diseaseNature2014505748455055424336208
- SatohJKinoYYamamotoYPLD3 is accumulated on neuritic plaques in Alzheimer’s disease brainsAlzheimers Res Ther2014697025478031
- Wetzel-SmithMKHunkapillerJBhangaleTRA rare mutation in UNC5C predisposes to late-onset Alzheimer’s disease and increases neuronal cell deathNat Med201420121452145725419706
- JiaoBLiuXTangBInvestigation of TREM2, PLD3, and UNC5C variants in patients with Alzheimer’s disease from mainland ChinaNeurobiol Aging201435102422.e92422.e1124866402
- HunkapillerJWetzelMBhangaleTA rare coding variant alters UNC5C function and predisposes to Alzheimer’s diseaseAlzheimers Dement201394853
- MaloneyJABainbridgeTGustafsonAMolecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor proteinJ Biol Chem201428945309903100025253696
- Mengel-FromJJeuneBPenttiTMcGueMChristensenKChristiansenLThe APP A673T frequency differs between Nordic countriesNeurobiol Aging201536102909.e12909.e426239177
- TingSKChongMSKandiahNAbsence of A673T amyloid-β precursor protein variant in Alzheimer’s disease and other neurological diseasesNeurobiol Aging201334102441.e72441.e823652020
- LogueMWSchuMVardarajanBNAlzheimer Disease Genetics ConsortiumAlzheimer Disease Genetics ConsortiumTwo rare AKAP9 variants are associated with Alzheimer’s disease in African AmericansAlzheimers Dement2014106609.e11618.e1125172201
- VenkateshDMrukDHerterJMAKAP9, a regulator of microtubule dynamics, contributes to blood-testis barrier functionAm J Pathol2016186227028426687990
- de VilliersCPvan der MerweLCrottiLAKAP9 is a genetic modifier of congenital long-QT syndrome type 1Circ Cardiovasc Genet20147559960625087618
- KimMSuhJRomanoDPotential late-onset Alzheimer’s disease-associated mutations in the ADAM10 gene attenuate α-secretase activityHum Mol Genet200918203987399619608551
- CaiGAtzmonGNajACEvidence against a role for rare ADAM10 mutations in sporadic Alzheimer diseaseNeurobiol Aging2012332416.e3417.e320381196
- SuhJChoiSHRomanoDMADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone functionNeuron201380238540124055016
- MorrisGPClarkIAVisselBInconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer’s diseaseActa Neuropathol Commun2014213525231068
- MullaneKWilliamsMAlzheimer’s therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?Biochem Pharmacol201385328930523178653